Cry34Ab1

From WikiMD's Wellness Encyclopedia

Cry34Ab1 is a protein that is part of a family of proteins known as Bacillus thuringiensis (Bt) toxins. These proteins are produced by the bacterium Bacillus thuringiensis, which is widely used in agriculture as a biological pesticide. Cry34Ab1, specifically, is used in conjunction with another protein, Cry35Ab1, to target and control certain pests, particularly rootworms in crops like corn.

Structure and Function[edit | edit source]

Cry34Ab1 is a binary toxin, which means it must act in concert with another protein (Cry35Ab1) to exert its pesticidal effect. The structure of Cry34Ab1 is distinct from the more common Cry proteins (such as Cry1 or Cry2 toxins), which are typically three-domain toxins. Cry34Ab1 is classified as a member of the binary toxin family due to its mode of action and its physical properties.

The protein functions by forming pores in the midgut cells of susceptible insects. This action disrupts the cellular function, leading to the death of the pest. The specificity of Cry34Ab1 and Cry35Ab1 is primarily towards the larvae of certain Coleoptera, notably the corn rootworm species, which are major pests in corn cultivation.

Agricultural Use[edit | edit source]

Cry34Ab1 is incorporated into genetically engineered corn varieties to provide built-in resistance to corn rootworms. This method of pest control is considered to be more environmentally friendly compared to traditional chemical insecticides, as it targets specific pests and reduces the need for broad-spectrum insecticidal sprays.

The use of Cry34Ab1 in genetically modified organisms (GMOs) has been a subject of regulatory review and approval in many countries, where it is evaluated for both efficacy and safety. The protein has been found to be safe for consumption and non-toxic to humans, wildlife, and beneficial insects that are not the target of the toxin.

Regulatory and Environmental Aspects[edit | edit source]

The introduction of Cry34Ab1 into agricultural practices has been accompanied by regulatory scrutiny to ensure that it does not pose risks to non-target organisms or lead to the development of resistance in target pest populations. Management strategies, including resistance management and crop rotation, are recommended to sustain the effectiveness of Cry34Ab1 and other Bt crops.

Conclusion[edit | edit source]

Cry34Ab1 represents a significant advancement in the field of agricultural biotechnology, offering an effective and sustainable approach to pest management in corn cultivation. Its development and use are examples of how modern biotechnology can contribute to sustainable agricultural practices.

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD